{
  "ticker": "DVL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969829",
  "id": "02969829",
  "pages": 25,
  "price_sensitive": false,
  "date": "20250716",
  "time": "1402",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250716/pdf/06lvh0nh2r28t2.pdf",
  "summary": "### **Material Information Summary (dorsaVi Ltd \u2013 EGM Notice)**  \n\n#### **Capital Raisings & Securities Issuances**  \n1. **Placement Details**  \n   - **Tranche 1 (Ratification):**  \n     - **105M shares** issued on 27-Jun-2025 at **$0.013/share** (Listing Rule 7.1).  \n     - **70M shares** issued on 04-Jul-2025 at **$0.013/share** (Listing Rule 7.1A).  \n   - **Tranche 2 (Approval):**  \n     - **12.5M shares** to be issued at **$0.013/share** (Listing Rule 7.1).  \n   - **Total Raised:** **~$2.44M** (before costs) across all tranches.  \n\n2. **Other Securities Issuances (Requiring Approval)**  \n   - **Options to 62 Capital:** **20M options** ($0.02 exercise price, 3-year expiry).  \n   - **Shares to Clayton Capital:** **60M shares** (nil consideration, for advisory services).  \n   - **Performance Rights to 62 Capital:** **40M rights** (vesting tied to share price milestones: $0.020, $0.025, $0.040 VWAP).  \n   - **Performance Rights to Directors:**  \n     - **10M each** to Gernot Abl & Leigh Travers (vesting at $0.020 and $0.030 VWAP).  \n   - **Shares to Dr. Andrew Ronchi:** **2.7M shares** (in lieu of $75,804 accrued leave).  \n\n#### **Key Dates**  \n- **EGM Date:** **15-Aug-2025** (11:00 AM AEST, virtual meeting).  \n- **Proxy Deadline:** **13-Aug-2025** (11:00 AM AEST).  \n\n#### **Use of Proceeds**  \n- Funds directed toward **RRAM technology integration** and **working capital**.  \n\n#### **Voting Exclusions**  \n- Related parties (e.g., directors, 62 Capital, Clayton Capital) excluded from voting on relevant resolutions.  \n\n**Format:** Concise bullet points, omitting boilerplate and non-material operational details. Focused on capital structure impacts (dilution, approvals) and trading-relevant deadlines. No material omissions detected.",
  "usage": {
    "prompt_tokens": 18814,
    "completion_tokens": 516,
    "total_tokens": 19330,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-16T05:19:47.287683"
}